Per the clinic, the patient experienced recurrent skin issues at the abutment site.On (b)(6) 2014, the patient experienced granulation tissue and inflammation at the abutment site and was prescribed a topical antibiotic.On (b)(6) 2014 a hypertrophy scar was removed from the abutment site.On (b)(6) 2014, the patient was administered an injection of depo-medrol.On (b)(6) 2014, a keloid was removed from the site.On (b)(6) 2015, the patient experienced pain and swelling, as well as cellulitis at the abutment site and was prescribed oral antibiotics.On (b)(6) 2015, the patient experienced purulent discharge at the abutment site and was prescribed another course of oral antibiotics.The patient developed subcutaneous scar tissue at the site which was excised on (b)(6) 2016.On (b)(6) 2016, the patient reported pain at the abutment site due to a hypertrophic scar and the site was injected with steroids.The implanted device remains.
|